Featured StoriesNewsState Eli Lilly drug, Bamlanivimab and Etesevimab, approved for COVID care by Jacob Walton | Editor-in-Chief March 9, 2022 The Food and Drug Administration (FDA) issued an emergency use authorization for a combination of Bamlanivimab and Etesevimab, a new prophylaxis drug for COVID-19 developed by Eli Lilly & Co,… 0 FacebookTwitterPinterestEmail